Alyeska Investment Group’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-137,345
| Closed | -$584K | – | 541 |
|
|
2018
Q2 | $584K | Buy |
+137,345
| New | +$584K | 0.01% | 384 |
|
|
2017
Q4 | – | Sell |
-964,116
| Closed | -$5.91M | – | 545 |
|
|
2017
Q3 | $5.91M | Buy |
964,116
+91,763
| +11% | +$563K | 0.04% | 263 |
|
|
2017
Q2 | $6.31M | Buy |
872,353
+722,353
| +482% | +$5.22M | 0.05% | 255 |
|
|
2017
Q1 | $795K | Buy |
+150,000
| New | +$795K | 0.01% | 427 |
|
|
2016
Q3 | – | Sell |
-1,508,548
| Closed | -$9.53M | – | 543 |
|
|
2016
Q2 | $9.53M | Buy |
1,508,548
+258,548
| +21% | +$1.63M | 0.09% | 256 |
|
|
2016
Q1 | $6.9M | Buy |
1,250,000
+564,448
| +82% | +$3.12M | 0.06% | 262 |
|
|
2015
Q4 | $3.83M | Buy |
685,552
+123,873
| +22% | +$691K | 0.04% | 269 |
|
|
2015
Q3 | $4.75M | Buy |
561,679
+418,427
| +292% | +$3.54M | 0.06% | 251 |
|
|
2015
Q2 | $2.17M | Buy |
143,252
+80,712
| +129% | +$1.22M | 0.02% | 322 |
|
|
2015
Q1 | $1M | Sell |
62,540
-18,564
| -23% | -$297K | 0.01% | 408 |
|
|
2014
Q4 | $1.45M | Sell |
81,104
-24,396
| -23% | -$435K | 0.02% | 348 |
|
|
2014
Q3 | $1.06M | Buy |
105,500
+73,483
| +230% | +$738K | 0.02% | 305 |
|
|
2014
Q2 | $500K | Sell |
32,017
-48,876
| -60% | -$763K | 0.01% | 341 |
|
|
2014
Q1 | $1.5M | Buy |
+80,893
| New | +$1.5M | 0.04% | 230 |
|